Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of CHF 5074 in Healthy Young Male Subjects.

Trial Profile

Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of CHF 5074 in Healthy Young Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Feb 2015

At a glance

  • Drugs CHF 5074 (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Chiesi
  • Most Recent Events

    • 18 Aug 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
    • 18 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Jul 2010 Tolerability and interim pharmacokinetic results presented at the 2010 International Conference on Alzheimer's Disease
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top